Patents by Inventor Gaëlle GENDRONNEAU

Gaëlle GENDRONNEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11331264
    Abstract: A fermented extract of aerial parts of Citrus aurantium and the process for obtaining it. The fermented extract may be added to a cosmetic composition. Also, the use of a fermented extract of Citrus aurantium to combat skin ageing, and also as an antioxidant active agent, to prevent/reduce oxidative stress and/or to detoxify the skin.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: May 17, 2022
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: David Legangneux, Alix Toribio, François Lejeune, Emmanuelle Bouissou-Cadio, Gaëlle Gendronneau
  • Publication number: 20200375883
    Abstract: A fermented extract of aerial parts of Citrus aurantium and the process for obtaining it. The fermented extract may be added to a cosmetic composition. Also, the use of a fermented extract of Citrus aurantium to combat skin ageing, and also as an antioxidant active agent, to prevent/reduce oxidative stress and/or to detoxify the skin.
    Type: Application
    Filed: May 26, 2020
    Publication date: December 3, 2020
    Applicant: CHANEL PARFUMS BEAUTE
    Inventors: David LEGANGNEUX, Alix TORIBIO, François LEJEUNE, Emmanuelle BOUISSOU-CADIO, Gaëlle GENDRONNEAU
  • Patent number: 10745755
    Abstract: The disclosure relates to the identification and the use of compounds which regulate the expression of at least one Sestrin gene, for preventing and/or attenuating skin ageing, and/or for hydrating the skin and/or for regulating skin pigmentation. The method includes the following steps: a. bringing at least one test compound in contact with a sample of human keratinocytes or melanocytes; b. measuring the expression of at least one Sestrin gene chosen from SESN3, SESN2 and SESN1 in the keratinocytes or melanocytes; c. selecting the compounds for which an activation of at least 1.6 fold of the expression of at least one of the genes is measured in the keratinocytes treated in a. compared with the untreated keratinocytes, or for which a significant modulation of the expression of at least one of the genes is measured in the melanocytes treated in a. compared with the untreated melanocytes.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: August 18, 2020
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: Gaelle Gendronneau, Irina Berlin, Francois Lejeune, Julie Latreille
  • Patent number: 10571476
    Abstract: Disclosed are methods for screening for candidate compounds for hydrating the skin. The compounds selected according to the methods disclosed therein stimulate the intra-cellular amount and/or activity of TonEBP in keratinocytes. Preferably, the selected compounds induce a stimulation of at least 20%, preferably at least 50%, preferably at least 100% of the activity and/or intra-cellular amount of TonEBP.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: February 25, 2020
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: Emmanuelle Bouissou-Cadio, Gaelle Gendronneau, Francois Lejeune, Irina Berlin
  • Patent number: 10532023
    Abstract: Disclosed is a Japanese camellia extract, obtained by extracting Camellia japonica flowers by way of a fatty substance or fatty substance mixture, and to a cosmetic composition including one such extract that has, in particular, a skin-moisturizing effect.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: January 14, 2020
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: Anne Rossignol-Castera, Annabelle L'Hermitte, Gaelle Gendronneau, Serge Holderith, Yannick Maestro
  • Patent number: 10206867
    Abstract: An alcoholic extract of aerial parts of Solidago virgaurea subsp. alpestris, the method of production thereof, a cosmetic or dermatological composition containing it, as well as cosmetic and dermatological uses thereof, notably in the treatment of signs of skin ageing.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: February 19, 2019
    Assignees: CHANEL PARFUMS BEAUTE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, UNIVERSITE DE NICE SOPHIA ANTIPOLIS
    Inventors: Serge Holderith, Anais Tromeur, Irina Berlin, Xavier Fernandez, Alexandre Casale, Johannes Grillari, Ingo Lammermann, Florian Gruber, Marie-Sophie Narzt, Gaëlle Gendronneau
  • Publication number: 20180223365
    Abstract: The disclosure relates to the identification and the use of compounds which regulate the expression of at least one Sestrin gene, for preventing and/or attenuating skin ageing, and/or for hydrating the skin and/or for regulating skin pigmentation. The method includes the following steps: a. bringing at least one test compound in contact with a sample of human keratinocytes or melanocytes; b. measuring the expression of at least one Sestrin gene chosen from SESN3, SESN2 and SESN1 in the keratinocytes or melanocytes; c. selecting the compounds for which an activation of at least 1.6 fold of the expression of at least one of the genes is measured in the keratinocytes treated in a. compared with the untreated keratinocytes, or for which a significant modulation of the expression of at least one of the genes is measured in the melanocytes treated in a. compared with the untreated melanocytes.
    Type: Application
    Filed: April 6, 2018
    Publication date: August 9, 2018
    Inventors: Gaëlle GENDRONNEAU, Irina BERLIN, Francois LEJEUNE, Julie LATREILLE
  • Publication number: 20180180629
    Abstract: Disclosed are methods for screening for candidate compounds for hydrating the skin. The compounds selected according to the methods disclosed therein stimulate the intra-cellular amount and/or activity of TonEBP in keratinocytes. Preferably, the selected compounds induce a stimulation of at least 20%, preferably at least 50%, preferably at least 100% of the activity and/or intra-cellular amount of TonEBP.
    Type: Application
    Filed: December 5, 2017
    Publication date: June 28, 2018
    Inventors: Emmanuelle BOUISSOU-CADIO, Gaelle GENDRONNEAU, Francois LEJEUNE, Irina BERLIN
  • Publication number: 20170275694
    Abstract: The disclosure relates to the identification and the use of compounds which regulate the expression of at least one Sestrin gene, for preventing and/or attenuating skin ageing, and/or for hydrating the skin and/or for regulating skin pigmentation. The method includes the following steps: a. bringing at least one test compound in contact with a sample of human keratinocytes or melanocytes; b. measuring the expression of at least one Sestrin gene chosen from SESN3, SESN2 and SESN1 in the keratinocytes or melanocytes; c. selecting the compounds for which an activation of at least 1.6 fold of the expression of at least one of the genes is measured in the keratinocytes treated in a. compared with the untreated keratinocytes, or for which a significant modulation of the expression of at least one of the genes is measured in the melanocytes treated in a. compared with the untreated melanocytes.
    Type: Application
    Filed: September 25, 2015
    Publication date: September 28, 2017
    Inventors: Gaelle GENDRONNEAU, Irina BERLIN, Francois LEJEUNE, Julie LATREILLE
  • Publication number: 20170216194
    Abstract: Disclosed is a Japanese camellia extract, obtained by extracting Camellia japonica flowers by way of a fatty substance or fatty substance mixture, and to a cosmetic composition including one such extract that has, in particular, a skin-moisturizing effect.
    Type: Application
    Filed: August 1, 2014
    Publication date: August 3, 2017
    Inventors: Anne ROSSIGNOL-CASTERA, Annabelle L'HERMITTE, Gaelle GENDRONNEAU, Serge HOLDERITH, Yannick MAESTRO